News

01/13/2010 — PhysioStim in Geneve : BIOSQUARE 1-2 February 2010

Feel free to visit and meet PhysioStim in Geneve.

11/27/2009 — NEW MODEL IN HOUSE: hCaV1.2 channel assays

PhysioStim added to its catalog of models a new ionic channel assays: hCaV1.2 channel assay. Cardiac calcium channel is largely involved in cardiac contraction and arrhythmia. Please, feel free to contact us for information regarding this model. laetitia.mercadieu@physiostim.com

11/27/2009 — PhysioStim will present BioPartnering North America- Vancouver- 25 January 2010 17h

Feel free to meet PhysioStim in Vancouver in B to B. http://www.techvision.com/bpn/ Consult our company profile and contact us. Marie Le Grand, CEO will present PhysioStim at 17h 25/01/10.

Home

Welcome to PhysioStim’s website!

« When I decided to create PhysioStim in 2000, I knew that a true economic and human challenge was awaiting me.
As an independent CRO specialized in cardiac electrophysiology, our wish was to remain and gain recognition as a niche CRO.
Today, our team includes 12 highly qualified and experienced electrophysiologists whose vocation is to design GLP in vitro pharmacology studies and R&D programs for the safe evaluation of your compounds.
Whether your company is a pharmaceutical or biotech one, this website has been designed for you. PhysioStim devotes all of its know-how, passion and enthusiasm in conducting customized safety pharmacology studies.
Built around strong values, our company is always turning to the future. Providing a more user-friendly and welcoming environment in which the safety of your compounds is at the heart of our main concerns.

I wish you a very pleasant visit of our PhysioStim website »

Marie Le Grand CEO